Your browser doesn't support javascript.
loading
Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement.
Mangione, Carol M; Barry, Michael J; Nicholson, Wanda K; Chelmow, David; Coker, Tumaini Rucker; Davis, Esa M; Donahue, Katrina E; Jaén, Carlos Roberto; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Rao, Goutham; Ruiz, John M; Stevermer, James; Tsevat, Joel; Underwood, Sandra Millon; Wong, John B.
Affiliation
  • Mangione CM; University of California, Los Angeles.
  • Barry MJ; Harvard Medical School, Boston, Massachusetts.
  • Nicholson WK; George Washington University, Washington, DC.
  • Chelmow D; Virginia Commonwealth University, Richmond.
  • Coker TR; University of Washington, Seattle.
  • Davis EM; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Donahue KE; University of North Carolina at Chapel Hill.
  • Jaén CR; University of Texas Health Science Center, San Antonio.
  • Kubik M; George Mason University, Fairfax, Virginia.
  • Li L; University of Virginia, Charlottesville.
  • Ogedegbe G; New York University, New York, New York.
  • Rao G; Case Western Reserve University, Cleveland, Ohio.
  • Ruiz JM; University of Arizona, Tucson.
  • Stevermer J; University of Missouri, Columbia.
  • Tsevat J; University of Texas Health Science Center, San Antonio.
  • Underwood SM; University of Wisconsin, Milwaukee.
  • Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
JAMA ; 329(15): 1290-1295, 2023 04 18.
Article in En | MEDLINE | ID: mdl-37071089
ABSTRACT
Importance Skin cancer is the most commonly diagnosed cancer in the US. There are different types of skin cancer varying in disease incidence and severity. Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons. However, persons with darker skin color are often diagnosed at later stages, when skin cancer is more difficult to treat.

Objective:

To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for skin cancer in asymptomatic adolescents and adults. Population Asymptomatic adolescents and adults who do not have a history of premalignant or malignant skin lesions. Evidence Assessment The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adolescents and adults. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults. (I statement).
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Carcinoma, Squamous Cell / Mass Screening / Early Detection of Cancer / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limits: Adolescent / Adult / Humans Language: En Journal: JAMA Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Carcinoma, Squamous Cell / Mass Screening / Early Detection of Cancer / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limits: Adolescent / Adult / Humans Language: En Journal: JAMA Year: 2023 Type: Article